Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02987166
Title HDCRT Plus Pembrolizumab in Advanced Malignancies (UVA-AM-001)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors James Larner, MD
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.